When faced with a new product that can be transformational to the field, the key issue becomes understanding the adoption dynamics, identifying the drivers of change within this dynamic, and then building a plan to deliver on transforming the adoption cycle.
Let’s reflect and challenge this situation assessing the requirements and changes needed to become a stronger voice with confidence, driving insights to action.
This session will draw connections between the global economy and healthcare spending across regions, and highlight the characteristics of the companies that are most successful in international markets.
Pharma brands confer meaning, too. But lately, meaning has taken a hit. There’s so much data, so many voices, so many alternative sets of facts. Can we really know or believe anything anymore? And how does this affect brands? This talk looks at how brands have evolved over the past several years, including consumer, B2B, and pharma brands, specifically in psoriasis. In a world where meaning is eroding, are brands losing ground? Or by contrast, more essential than ever? The evidence may surprise you.
It is imperative to place patients first, in an open and sustained environment to respectfully and compassionately achieve the best outcome for them and their family. Unfortunately, communication between patients and the rest of the healthcare mechanism continues to be the missing link, which has so far prevented the former from being an active part of the conversation, the deliberation, the development, and the execution.
Our presentation elaborates on how the healthcare sector can overcome this problem opening a more direct and efficient line of a feedback system with patients through digital technology. The idea is to gather conscious and indirect patient inputs and digitally capture patient information (everything around authentic emotions, pain points, needs, unmet needs both on patient and caregiver side shortly after diagnosis, what their thoughts are when it comes to drug choices and therapy decisions) to better healthcare. This could enhance the ability of healthcare providers as well as researchers to address finer challenges and help pharma companies to make new approach based developments through an understanding of patients’ experiences and actual needs. Thus opening up new possibilities for the future of healthcare, including healthcare research that’s more patient-centric.
• Keeping focus & being creative
• Engaging key opinion leaders
Key words: innovation, strategy, start-ups, consumer insights
A discussion on different approaches used by big corporations and start-ups when innovating: we´ll be able to make a comparison, discuss the best practices and learn from both perspectives.